IC
GMAB icon

IEQ Capital’s Genmab GMAB Stock Holding History

IEQ Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Buy
16,862
+115
+0.7% +$3.06K ﹤0.01% 1431
2026
Q1 		$449K Sell
16,747
-374
-2% -$11.2K ﹤0.01% 1356
2025
Q4 		$527K Buy
17,121
+1,218
+8% +$38K ﹤0.01% 1307
2025
Q3 		$488K Buy
+15,903
New +$388K ﹤0.01% 1302

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IEQ Capital's GMAB Position: Q2 2026 in Review

IEQ Capital increased its Genmab (GMAB) stake by 0.69% in Q2 2026, buying an estimated $3.06K and bringing the position to 16,862 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

IEQ Capital first reported a position in GMAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $527K in Q4 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • IEQ Capital held 16,862 shares of Genmab worth $463K as of Q2 2026.
  • IEQ Capital bought 115 Genmab shares in Q2 2026, an estimated $3.06K.
  • Genmab made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1431 holding.
  • IEQ Capital first reported a position in Genmab in Q3 2025 and has held it in 4 quarters since.
  • IEQ Capital's Genmab position peaked at $527K in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.